Treatment of acute myelogenous leukaemia in patients aged...

British Journal of Haematology 1996 Vol. 94; Iss. 2

Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course

B. Pignon, F. Witz, B. Desablens, P. Y. Leprise, S. Francois, C. Linassier, C. Berthou, D. Caillot, B. Lioure, J. Y. Cahn, P. Casassus, A. Sadoun, B. Audhuy, D. Guyotat, J. Briere, J. P. Vilque, L. Ba
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
94
Year:
1996
Language:
english
Pages:
9
DOI:
10.1046/j.1365-2141.1996.d01-1803.x
File:
PDF, 284 KB
english, 1996
Conversion to is in progress
Conversion to is failed